Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.06
NAS:MDRX's Cash to Debt is ranked lower than
95% of the 1925 Companies
in the Global Software - Application industry.

( Industry Median: 6.46 vs. NAS:MDRX: 0.06 )
Ranked among companies with meaningful Cash to Debt only.
NAS:MDRX' s Cash to Debt Range Over the Past 10 Years
Min: 0.06  Med: 0.72 Max: No Debt
Current: 0.06
Equity to Asset 0.35
NAS:MDRX's Equity to Asset is ranked lower than
80% of the 1823 Companies
in the Global Software - Application industry.

( Industry Median: 0.61 vs. NAS:MDRX: 0.35 )
Ranked among companies with meaningful Equity to Asset only.
NAS:MDRX' s Equity to Asset Range Over the Past 10 Years
Min: 0.3  Med: 0.6 Max: 0.96
Current: 0.35
0.3
0.96
Interest Coverage 1.85
NAS:MDRX's Interest Coverage is ranked lower than
94% of the 1488 Companies
in the Global Software - Application industry.

( Industry Median: 166.16 vs. NAS:MDRX: 1.85 )
Ranked among companies with meaningful Interest Coverage only.
NAS:MDRX' s Interest Coverage Range Over the Past 10 Years
Min: 0.82  Med: 5.97 Max: 52.48
Current: 1.85
0.82
52.48
F-Score: 6
Z-Score: 0.82
M-Score: -2.63
WACC vs ROIC
7.79%
2.29%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 4.79
NAS:MDRX's Operating margin (%) is ranked higher than
50% of the 1874 Companies
in the Global Software - Application industry.

( Industry Median: 4.72 vs. NAS:MDRX: 4.79 )
Ranked among companies with meaningful Operating margin (%) only.
NAS:MDRX' s Operating margin (%) Range Over the Past 10 Years
Min: -9.29  Med: 8.02 Max: 14.84
Current: 4.79
-9.29
14.84
Net-margin (%) -0.13
NAS:MDRX's Net-margin (%) is ranked lower than
64% of the 1874 Companies
in the Global Software - Application industry.

( Industry Median: 3.09 vs. NAS:MDRX: -0.13 )
Ranked among companies with meaningful Net-margin (%) only.
NAS:MDRX' s Net-margin (%) Range Over the Past 10 Years
Min: -7.58  Med: 4.92 Max: 8.92
Current: -0.13
-7.58
8.92
ROE (%) -0.14
NAS:MDRX's ROE (%) is ranked lower than
65% of the 1817 Companies
in the Global Software - Application industry.

( Industry Median: 5.66 vs. NAS:MDRX: -0.14 )
Ranked among companies with meaningful ROE (%) only.
NAS:MDRX' s ROE (%) Range Over the Past 10 Years
Min: -7.99  Med: 5.37 Max: 10.96
Current: -0.14
-7.99
10.96
ROA (%) -0.06
NAS:MDRX's ROA (%) is ranked lower than
62% of the 1929 Companies
in the Global Software - Application industry.

( Industry Median: 2.83 vs. NAS:MDRX: -0.06 )
Ranked among companies with meaningful ROA (%) only.
NAS:MDRX' s ROA (%) Range Over the Past 10 Years
Min: -4.19  Med: 3.41 Max: 6.14
Current: -0.06
-4.19
6.14
ROC (Joel Greenblatt) (%) 38.14
NAS:MDRX's ROC (Joel Greenblatt) (%) is ranked higher than
59% of the 1892 Companies
in the Global Software - Application industry.

( Industry Median: 21.43 vs. NAS:MDRX: 38.14 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NAS:MDRX' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -74.39  Med: 80.96 Max: 516.74
Current: 38.14
-74.39
516.74
Revenue Growth (3Y)(%) -2.50
NAS:MDRX's Revenue Growth (3Y)(%) is ranked lower than
70% of the 1456 Companies
in the Global Software - Application industry.

( Industry Median: 5.00 vs. NAS:MDRX: -2.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NAS:MDRX' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -28.6  Med: 9.85 Max: 24.3
Current: -2.5
-28.6
24.3
EBITDA Growth (3Y)(%) 4.80
NAS:MDRX's EBITDA Growth (3Y)(%) is ranked lower than
55% of the 1203 Companies
in the Global Software - Application industry.

( Industry Median: 7.90 vs. NAS:MDRX: 4.80 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
NAS:MDRX' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -68.8  Med: 6 Max: 105.4
Current: 4.8
-68.8
105.4
» NAS:MDRX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

MDRX Guru Trades in Q4 2015

Jim Simons 557,465 sh (New)
Joel Greenblatt 1,479,705 sh (+140.78%)
First Eagle Investment 5,165,618 sh (+6.14%)
Vanguard Health Care Fund 11,198,893 sh (unchged)
Michael Price 477,500 sh (unchged)
George Soros Sold Out
Third Avenue Management 297,524 sh (-0.06%)
Chuck Royce 1,638,300 sh (-5.85%)
RS Investment Management 3,556,537 sh (-33.99%)
» More
Q1 2016

MDRX Guru Trades in Q1 2016

First Eagle Investment 5,963,023 sh (+15.44%)
Chuck Royce 1,643,400 sh (+0.31%)
Vanguard Health Care Fund 11,198,893 sh (unchged)
Michael Price 477,500 sh (unchged)
Jim Simons Sold Out
RS Investment Management 2,866,712 sh (-19.40%)
Third Avenue Management 204,351 sh (-31.32%)
Joel Greenblatt 160,157 sh (-89.18%)
» More
Q2 2016

MDRX Guru Trades in Q2 2016

Jim Simons 251,865 sh (New)
Paul Tudor Jones 36,902 sh (New)
Joel Greenblatt 186,620 sh (+16.52%)
Chuck Royce 1,666,900 sh (+1.43%)
Third Avenue Management 204,351 sh (unchged)
Michael Price 477,500 sh (unchged)
Vanguard Health Care Fund 11,198,893 sh (unchged)
RS Investment Management 2,864,495 sh (-0.08%)
First Eagle Investment 4,774,073 sh (-19.94%)
» More
Q3 2016

MDRX Guru Trades in Q3 2016

Steven Cohen 347,900 sh (New)
Jim Simons 698,465 sh (+177.32%)
Third Avenue Management 204,351 sh (unchged)
Michael Price 477,500 sh (unchged)
Vanguard Health Care Fund 11,198,893 sh (unchged)
Joel Greenblatt Sold Out
Chuck Royce 1,645,400 sh (-1.29%)
First Eagle Investment 4,578,690 sh (-4.09%)
Paul Tudor Jones 16,800 sh (-54.47%)
» More
» Details

Insider Trades

Latest Guru Trades with MDRX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Application Software » Software - Application
Compare:NYSE:HUBS, NAS:CSOD, NAS:EBIX, NYSE:ZEN, NAS:STMP, NAS:SYNA, NAS:SNCR, NYSE:LOCK, NAS:MSTR, NAS:FEYE, NAS:ACIW, NAS:RP, NYSE:LXFT, NAS:PCTY, NYSE:FLTX, NAS:MANT, OTCPK:ISMAY, NAS:VRNT, NAS:DSGX, NYSE:RNG » details
Traded in other countries:AL21.Germany,
Allscripts Healthcare Solutions Inc is a provider of clinical, financial, connectivity and information solutions and related professional services that empower hospitals, physicians and post-acute organizations to deliver world-class outcomes.

Allscripts Healthcare Solutions Inc was founded in 1986. The Company provides clinical, financial, connectivity and information solutions and related professional services that empower hospitals, physicians and post-acute organizations to deliver world-class outcomes. The Company operates in three reportable segments: Clinical and Financial Solutions, Population Health. The Clinical and Financial Solutions segment includes its Acute, TouchWorks, Professional Practices, Payer and Life Sciences, and International strategic business units. These solutions include EHR-related software, financial and practice management software, related installation and training services, and electronic claims administration services. The Population Health segment includes its Performance and Care Logistics and Population Health strategic business units. The Company delivers solutions that provide physicians and other healthcare professionals with the data, information, insights, and connectivity required to transform health care by improving the quality and efficiency of patient care and to navigate the transition from fee-for-service to value-based care. It provides solutions for home care, hospice, skilled nursing, and other post-acute organizations. These range from a fully integrated EHR and financial management solution to referral management. The Company offers several types of solutions that are tailored towards different segments of the market in which it operates and which support healthcare delivery in every care setting. It also offers various add-ons to increase the functionality of its product offerings. The Company competes with AmazingCharts.com, Inc., Aprima Medical Software, athenahealth Inc., Cerner Corporation, Computer Programs and Systems Inc., CureMD Healthcare, Curaspan Health Group, eClinicalWorks LLC, Emdeon, Epic Systems Corporation, Evolent Health, GE Healthcare Technologies, GE Management Systems, Healthagen, Healthcatalysts, Homecare Homebase (now controlled by Hearst Corporation), IBM Corporation, Infor-Med Medical Information Systems Inc., McKesson Corporation, MEDHOST, Inc., Medical Information Technology, Inc. (Meditech), Midas+, NextTech Systems, Optum (a division of United HealthCare Corporation), PracticeFusion, Inc., Quadramed, Quality Systems, Inc., Quest Diagnostics, Roper Industries, T-System, The Trizetto Group, Inc., Vitera Healthcare Solutions, Wellcentive and Wellsoft Corporation.

Ratios

vs
industry
vs
history
Forward P/E 15.87
MDRX's Forward P/E is ranked higher than
70% of the 296 Companies
in the Global Software - Application industry.

( Industry Median: 20.75 vs. MDRX: 15.87 )
Ranked among companies with meaningful Forward P/E only.
N/A
Price/Owner Earnings (ttm) 19.37
MDRX's Price/Owner Earnings (ttm) is ranked higher than
60% of the 734 Companies
in the Global Software - Application industry.

( Industry Median: 23.79 vs. MDRX: 19.37 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
MDRX' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 8.8  Med: 41.06 Max: 14600
Current: 19.37
8.8
14600
P/B 1.44
MDRX's P/B is ranked higher than
75% of the 1859 Companies
in the Global Software - Application industry.

( Industry Median: 2.78 vs. MDRX: 1.44 )
Ranked among companies with meaningful P/B only.
MDRX' s P/B Range Over the Past 10 Years
Min: 0.79  Med: 2.22 Max: 7.86
Current: 1.44
0.79
7.86
P/S 1.35
MDRX's P/S is ranked higher than
64% of the 1866 Companies
in the Global Software - Application industry.

( Industry Median: 2.20 vs. MDRX: 1.35 )
Ranked among companies with meaningful P/S only.
MDRX' s P/S Range Over the Past 10 Years
Min: 0.9  Med: 2.41 Max: 7.04
Current: 1.35
0.9
7.04
PFCF 13.01
MDRX's PFCF is ranked higher than
78% of the 702 Companies
in the Global Software - Application industry.

( Industry Median: 25.00 vs. MDRX: 13.01 )
Ranked among companies with meaningful PFCF only.
MDRX' s PFCF Range Over the Past 10 Years
Min: 10.06  Med: 43.32 Max: 2138.46
Current: 13.01
10.06
2138.46
POCF 7.40
MDRX's POCF is ranked higher than
85% of the 886 Companies
in the Global Software - Application industry.

( Industry Median: 16.86 vs. MDRX: 7.40 )
Ranked among companies with meaningful POCF only.
MDRX' s POCF Range Over the Past 10 Years
Min: 5.77  Med: 22.92 Max: 79.2
Current: 7.4
5.77
79.2
EV-to-EBIT 62.89
MDRX's EV-to-EBIT is ranked lower than
85% of the 1231 Companies
in the Global Software - Application industry.

( Industry Median: 17.27 vs. MDRX: 62.89 )
Ranked among companies with meaningful EV-to-EBIT only.
MDRX' s EV-to-EBIT Range Over the Past 10 Years
Min: -1965.5  Med: 36.3 Max: 540.1
Current: 62.89
-1965.5
540.1
EV-to-EBITDA 15.28
MDRX's EV-to-EBITDA is ranked lower than
55% of the 1335 Companies
in the Global Software - Application industry.

( Industry Median: 13.23 vs. MDRX: 15.28 )
Ranked among companies with meaningful EV-to-EBITDA only.
MDRX' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.1  Med: 23.65 Max: 83.8
Current: 15.28
7.1
83.8
Shiller P/E 184.70
MDRX's Shiller P/E is ranked lower than
97% of the 289 Companies
in the Global Software - Application industry.

( Industry Median: 36.25 vs. MDRX: 184.70 )
Ranked among companies with meaningful Shiller P/E only.
MDRX' s Shiller P/E Range Over the Past 10 Years
Min: 43.43  Med: 114.33 Max: 220.83
Current: 184.7
43.43
220.83
Current Ratio 0.94
MDRX's Current Ratio is ranked lower than
85% of the 1848 Companies
in the Global Software - Application industry.

( Industry Median: 1.97 vs. MDRX: 0.94 )
Ranked among companies with meaningful Current Ratio only.
MDRX' s Current Ratio Range Over the Past 10 Years
Min: 0.93  Med: 1.7 Max: 23.84
Current: 0.94
0.93
23.84
Quick Ratio 0.94
MDRX's Quick Ratio is ranked lower than
82% of the 1848 Companies
in the Global Software - Application industry.

( Industry Median: 1.82 vs. MDRX: 0.94 )
Ranked among companies with meaningful Quick Ratio only.
MDRX' s Quick Ratio Range Over the Past 10 Years
Min: 0.73  Med: 1.65 Max: 23.25
Current: 0.94
0.73
23.25
Days Sales Outstanding 99.34
MDRX's Days Sales Outstanding is ranked lower than
74% of the 1495 Companies
in the Global Software - Application industry.

( Industry Median: 67.08 vs. MDRX: 99.34 )
Ranked among companies with meaningful Days Sales Outstanding only.
MDRX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 76.24  Med: 88.76 Max: 105.33
Current: 99.34
76.24
105.33
Days Payable 40.90
MDRX's Days Payable is ranked lower than
52% of the 1331 Companies
in the Global Software - Application industry.

( Industry Median: 43.28 vs. MDRX: 40.90 )
Ranked among companies with meaningful Days Payable only.
MDRX' s Days Payable Range Over the Past 10 Years
Min: 19.32  Med: 30.68 Max: 47.95
Current: 40.9
19.32
47.95

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -3.20
MDRX's 3-Year Average Share Buyback Ratio is ranked lower than
55% of the 1152 Companies
in the Global Software - Application industry.

( Industry Median: -2.50 vs. MDRX: -3.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MDRX' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -102.2  Med: -10.8 Max: 1.8
Current: -3.2
-102.2
1.8

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.09
MDRX's Price/Projected FCF is ranked higher than
76% of the 805 Companies
in the Global Software - Application industry.

( Industry Median: 1.89 vs. MDRX: 1.09 )
Ranked among companies with meaningful Price/Projected FCF only.
MDRX' s Price/Projected FCF Range Over the Past 10 Years
Min: 1.01  Med: 1.83 Max: 6.69
Current: 1.09
1.01
6.69
Price/Median PS Value 0.58
MDRX's Price/Median PS Value is ranked higher than
89% of the 1534 Companies
in the Global Software - Application industry.

( Industry Median: 1.08 vs. MDRX: 0.58 )
Ranked among companies with meaningful Price/Median PS Value only.
MDRX' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.48  Med: 1.04 Max: 12.05
Current: 0.58
0.48
12.05
Earnings Yield (Greenblatt) (%) 1.58
MDRX's Earnings Yield (Greenblatt) (%) is ranked lower than
54% of the 1940 Companies
in the Global Software - Application industry.

( Industry Median: 2.20 vs. MDRX: 1.58 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MDRX' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.2  Med: 2.1 Max: 5.9
Current: 1.58
0.2
5.9
Forward Rate of Return (Yacktman) (%) 1.36
MDRX's Forward Rate of Return (Yacktman) (%) is ranked lower than
71% of the 748 Companies
in the Global Software - Application industry.

( Industry Median: 10.33 vs. MDRX: 1.36 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MDRX' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -12.4  Med: 1.45 Max: 69.6
Current: 1.36
-12.4
69.6

More Statistics

Revenue (TTM) (Mil) $1,470
EPS (TTM) $ -0.01
Beta1.19
Short Percentage of Float9.88%
52-Week Range $9.80 - 15.57
Shares Outstanding (Mil)185.09

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 1,551 1,681 1,778
EPS ($) 0.57 0.68 0.77
EPS w/o NRI ($) 0.57 0.68 0.77
EPS Growth Rate
(3Y to 5Y Estimate)
19.14%
Dividends Per Share ($)
» More Articles for NAS:MDRX

Headlines

Articles On GuruFocus.com
The Moat Stays Strong, Even If the Listing Is Gone Oct 24 2016 
Companies Fall to 5-Year Lows Jun 22 2016 
Third Avenue Cuts Stake in Powell, BlackRock Dec 29 2015 
First Eagle Investment Buys 19 Stakes in Second Quarter Aug 17 2015 
Columbia Management's Top 5 New Buys Amid Buoyant Outlook Aug 12 2013 
Weekly CEO Buys Highlight: AKAM, DRC, MDRX, MTG, CDXS Mar 17 2013 
American Insider Trades: March 8-15 Mar 15 2013 
The Barclays Triggers More Insider Buying Mar 13 2013 
Allscripts-Misys Reports 5 Insider Buys the Day Before Barclays Conference Mar 13 2013 
Edward Owens’ 3 Biggest Stock Increases Feb 05 2013 

More From Other Websites
Los Angeles County selects EZ-CAP to afford greater care access across the community Dec 08 2016
Allscripts Buys Core Medical Solutions, Expands in Australia Dec 06 2016
Allscripts to extend EMR offerings in Australia Dec 04 2016
Hedge Funds Aren’t Crazy About BGC Partners, Inc. (BGCP) Anymore Dec 02 2016
Coverage initiated on Allscripts Healthcare by Dougherty & Company Dec 02 2016
Should You Buy Summit Materials Inc (SUM)? Dec 01 2016
2bPrecise, an Allscripts company, partners with Holston Medical Group to launch early adopter... Nov 29 2016
Here is What Hedge Funds Think About Allscripts Healthcare Solutions Inc (MDRX) Nov 26 2016
Allscripts Healthcare (MDRX) to Repurchase $200M Share Nov 18 2016
Allscripts Announces Expanded Share Repurchase Program Nov 17 2016
Allscripts Announces Expanded Share Repurchase Program Nov 17 2016
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. Financials Nov 16 2016
ETFs with exposure to Allscripts Healthcare Solutions, Inc. : November 14, 2016 Nov 14 2016
Allscripts Healthcare Solutions, Inc. :MDRX-US: Earnings Analysis: Q3, 2016 By the Numbers :... Nov 11 2016
Allscripts (MDRX) Beats on Earnings in Q3, Revenues Miss Nov 11 2016
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. Files SEC form 10-Q, Quarterly Report Nov 04 2016
Allscripts Posts 3Q Loss, Cuts 4Q Outlook (MDRX) Nov 04 2016
Allscripts (MDRX) Stock Stumbles as Q3 Results Miss Expectations Nov 04 2016
[$$] Allscripts Healthcare Results Miss Expectations Nov 03 2016
AllScripts reports 3Q loss Nov 03 2016
AllScripts reports 3Q loss Nov 03 2016
Allscripts Healthcare Solutions Inc Earnings Call scheduled for 4:30 pm ET today Nov 03 2016
Allscripts announces third quarter 2016 results Nov 03 2016
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. Files SEC form 8-K, Results of Operations and Financial... Nov 03 2016
Allscripts announces third quarter 2016 results Nov 03 2016
Allscripts to extend its comprehensive population health management platform Oct 20 2016
Baylor Scott & White Health Utilizes Allscripts dbMotion™ Solution to Connect Multiple EHR Systems Oct 13 2016
Allscripts to release third quarter 2016 financial results November 3 Oct 06 2016
OptimizeRx and Allscripts Expand Partnership to Increase Focus on Clinical Messaging for... Oct 05 2016
Wise Health System selects Allscripts to improve patient care and population health Sep 13 2016
Allscripts announces Allscripts eRecruit, new initiative to improve population health Sep 08 2016
King's College Hospital launches Allscripts Sunrise(TM) Sep 02 2016
King’s College Hospital launches Allscripts Sunrise™ Sep 01 2016
The Bahamian Ministry of Health and Public Hospitals Authority select Allscripts Sunrise™ Aug 16 2016
Medlio and PatientLink Enterprises Win Allscripts Open API Patient Engagement Challenge Aug 10 2016
Allscripts and Hospital IQ Partner to Improve Hospital Operational Efficiency with Predictive... Aug 09 2016
2bPrecise, an Allscripts company, launches a Genomics and Precision Medicine Initiative at National... Aug 08 2016
AllScripts reports 2Q loss Aug 04 2016
OptumCare Selects Allscripts to Provide its Physicians a Connected Health IT Platform Aug 04 2016
Allscripts announces second quarter 2016 results Aug 04 2016
Wyckoff Heights Medical Center selects Allscripts Sunrise™ Aug 01 2016
Allscripts to release second quarter 2016 financial results August 4 Jul 05 2016
Allscripts reinvigorating its EPSi™ business to accelerate innovation, drive client success Jun 27 2016
Allscripts earns top spot in 2016 ambulatory EHR user satisfaction poll from Black Book Rankings(TM) Jun 09 2016
AllScripts tops 1Q profit forecasts May 05 2016
AllScripts meets 4Q profit forecasts Feb 18 2016
AllScripts reports 3Q loss Nov 05 2015
AllScripts reports 2Q loss Aug 04 2015
AllScripts reports 1Q loss May 07 2015
AllScripts reports 4Q loss Feb 26 2015
AllScripts Healthcare reports 3Q loss Nov 06 2014
Exclusive: Apple prepares Healthkit rollout amid tangled regulatory web Aug 12 2014
EXCLUSIVE - Apple prepares Healthkit rollout amid tangled regulatory web Aug 12 2014
Exclusive - Apple prepares Healthkit rollout amid tangled regulatory web Aug 12 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)